Mon, May 27, 2024
Zee Business analyst Kushal Gupta suggests investors buy pharma stock Zydus Lifesciences for one year. On Monday, May 27, the stock closed at Rs 1,058.6 each, up 1.6 per cent or 17.35 per share on BSE.
More >
Sat, Dec 03, 2016
Drug firm Zydus Cadila on Saturday said the patent litigation relating to Allergan's Delzicol, used to treat ulcerative colitis, has been settled. The patent litigation relating to Allergan's Delzicol (mesalamine) has been settled, Zydus Cadila said in a statement.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
